PLXNA3 and colorectal carcinoma: We subsequently focused our study on CRC, integrating bulk transcriptomic, spatial transcriptomic, single-cell RNA sequencing, immunohistochemistry, and pharmacogenomic data to comprehensively assess PLXNA3 at multiple biological levels.